FPT-EUROPE
FPT Europe, a subsidiary of the global technology services provider FPT Corporation, has announced the collaboration with innogy Czech, a leading energy company providing natural gas, electricity and heating solutions, as well as clean mobility solutions, to migrate the innogy Czech’s entire SAP R/3-based ERP infrastructure to the SaaS cloud. As the general contractor of the project, FPT will support the customer to migrate the current system to SAP S/4HANA as part of the greenfield approach. The goal is thus a complete redesign of the Enterprise Resource Planning (ERP), which is business-critical for innogy Czech, including streamlining and simplifying all processes automated in the system. FPT is responsible for the entire scope of the project, from consulting to planning and implementation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210817005685/en/
"We entrusted FPT with the upgrade of our SAP system to S/4 HANA because of the company’s expertise, technical capabilities and years of experience in the industry," says Miloš Dušek, Senior Manager of Corporate Applications at innogy Ceska republika. "The project is of great strategic importance for innogy. FPT has proven to be a reliable strategic partner for us and has put together a qualified team to ensure that the first part of the project will be delivered successfully by the end of 2021."
Lighthouse project in the growing market of SAP S/4HANA
The aim of the project is to replace the current SAP ERP system used by innogy Czech in version R/3 ERP Central Component 6.0 EhP 8, which has so far been based on HANA DB2, with S/4HANA Private Cloud Edition. "SAP made an announcement that the company will end the support for its on-premises solutions by 2027. Many companies therefore would want to migrate their system to S/4 HANA in a timely manner," explains Andy Do, Deputy Director/Head of Delivery at FPT Europe. "FPT has strong expertise and many years of experience in cloud migration as well as SAP migration projects, but the project with innogy Czech can be considered as one of the largest end-to-end S/4HANA migration projects for us. It offers FPT a great opportunity to position ourselves as a trusted partner in the field of SAP S/4HANA migration."
The scope of work mentioned above will be applied for 5 companies within innogy Czech Republic group, including innogy Ceska republika a.s., innogy Zakaznicke sluzby, s.r.o., innogy Energie, s.r.o., innogy Energo, s.r.o. and innogy Energetika Plhov-Nachod, s.r.o.
FPT has more than 20 years of experience in providing services related to SAP. With a pool of more than 300 functional and 250 technical consultants, FPT has successfully implemented and rolled out SAP systems for customers in Southeast Asia, Japan and Europe. With SAP S/4HANA, FPT offers a wide range of services such as development, implementation and rollout. FPT also offers its own solutions in the field of Application Managed Services (AMS). FPT’s services in the areas of SAP migration, SAP customization, SAP rollout and SAP Automation Testing help its customers assure smooth and efficient implementation of SAP S/4HANA.
About FPT Europe
FPT Europe, based in Essen, Germany is a part of FPT Corporation - a technology and IT services provider headquartered in Vietnam with nearly US$2 billion in revenue and 36,000 employees. Being a pioneer in digital transformation, the company delivers world-class services in Smart factory, Digital platforms, RPA, AI, IoT, Data Analytics, Mobility, Cloud, Managed Services, Testing. FPT Software has served over 700 customers worldwide, 100 of which are Fortune 500 companies in the industries of Aerospace & Aviation, Automotive, Banking and Finance, Communications, Media and Services, Logistics & Transportation, Utilities, Consumer Packaged Goods, Healthcare, Manufacturing, Public sector, Technology and so on. Established in 2012, FPT Europe has become technology partners of 50 leading companies including Siemens, RWE, Allianz, Schaeffler, Airbus, Carlsberg and many more. For other information, please visit: www.fpt-europe.de
About innogy Czech
innogy Česká republika is a leading energy company in the Czech Republic owned by the largest Hungarian energy group MVM. innogy supplies 1.6 million customers with energy and energy-related innovative services. First class customer service is provided by own call centres and a chain of customer service centres. In addition to gas and electricity supplies, innogy produces heat and electricity in heating plants across the country with an annual heat production of 900,000 GJ. Aside from the core business, innogy focuses on clean mobility, photovoltaics and energy management services. With a nationwide network of 60+ filling stations, own CNG technology production and more than 10 million kg CNG sold annually, innogy is a strong market leader. innogy is also building up a solid position in the fast-growing solar power plants market. The company employs 1,500 highly skilled people and the innogy brand is known to more than 90% of the Czech population.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210817005685/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom